Principal Financial Group’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.43M | Buy |
|
|||||
|
2025
Q1 | $4.02M | Buy |
|
|||||
|
2024
Q4 | $6.05M | Buy |
|
|||||
|
2024
Q3 | $11.7M | Sell |
|
|||||
|
2024
Q2 | $11M | Sell |
|
|||||
|
2024
Q1 | $10M | Sell |
|
|||||
|
2023
Q4 | $9.03M | Buy |
|
|||||
|
2023
Q3 | $7.25M | Sell |
|
|||||
|
2023
Q2 | $11M | Sell |
|
|||||
|
2023
Q1 | $11.6M | Sell |
|
|||||
|
2022
Q4 | $7.35M | Sell |
|
|||||
|
2022
Q3 | $9.89M | Sell |
|
|||||
|
2022
Q2 | $9.8M | Sell |
|
|||||
|
2022
Q1 | $14.5M | Sell |
|
|||||
|
2021
Q4 | $16.5M | Sell |
|
|||||
|
2021
Q3 | $20.9M | Sell |
|
|||||
|
2021
Q2 | $19.8M | Buy |
|
|||||
|
2021
Q1 | $18.6M | Buy |
|
|||||
|
2020
Q4 | $11.8M | Sell |
|
|||||
|
2020
Q3 | $8.6M | Buy |
|
|||||
|
2020
Q2 | $7.15M | Buy |
|
|||||
|
2020
Q1 | $8.4M | Sell |
|
|||||
|
2019
Q4 | $16.6M | Sell |
|
|||||
|
2019
Q3 | $17.9M | Buy |
|
|||||
|
2019
Q2 | $17.3M | Sell |
|
|||||
|
2019
Q1 | $20.8M | Sell |
|
|||||
|
2018
Q4 | $18.7M | Buy |
|
|||||
|
2018
Q3 | $28.3M | Buy |
|
|||||
|
2018
Q2 | $21.8M | Sell |
|
|||||
|
2018
Q1 | $17.2M | Buy |
|
|||||
|
2017
Q4 | $19.3M | Buy |
|
|||||
|
2017
Q3 | $19M | Sell |
|
|||||
|
2017
Q2 | $13.7M | Sell |
|
|||||
|
2017
Q1 | $10.2M | Buy |
|
|||||
|
2016
Q4 | $207K | Buy |
|
|||||
|
2016
Q3 | $247K | Buy |
|
|||||
|
2016
Q2 | $364K | Sell |
|
|||||
|
2016
Q1 | $457K | Buy |
|
|||||
|
2015
Q4 | $516K | Hold |
|
|||||
|
2015
Q3 | $448K | Sell |
|
|||||
|
2015
Q2 | $407K | Sell |
|
|||||
|
2015
Q1 | $644K | Sell |
|
|||||
|
2014
Q4 | $861K | Sell |
|
|||||
|
2014
Q3 | $1.08M | Sell |
|
|||||
|
2014
Q2 | $1.14M | Sell |
|
|||||
|
2014
Q1 | $1M | Sell |
|
|||||
|
2013
Q4 | $666K | Hold |
|
|||||
|
2013
Q3 | $746K | Sell |
|
|||||
|
2013
Q2 | $1.09M | Buy |
|